Lipella Pharmaceuticals Inc - LIPO Earnings per share for the trailing year

Lipella Pharmaceuticals Inc (LIPO) - corporate logo

The strategy of outsourcing production and testing minimizes capital expenditures for Lipella Pharmaceuticals (LIPO). This rolling annual EPS growth chart confirms the impact of such a model on assets, where -63.80 reflects the metric's baseline. Future growth relies on the planned capacity of R&D laboratories and the diversification of pilot batches, as well as strict adherence to bioethical norms and ESG environmental standards.

lipella.com (LIPO): Earnings per share for the last twelve months from 02/11/2024 to 02/20/2024

lipella.com - analytical breakdowns and key metrics (LIPO)

- issuer market value details:
Initial company analysis:Lipella Pharmaceuticals, Inc.
Flagship merchandise of Lipella Pharmaceuticals

Professional managers utilize fundamental filters to separate speculative assets from sustainable businesses. This metric measures the percentage change in net income per share over a rolling year, reflecting the actual efficiency of capital generation. For Lipella Pharmaceuticals (LIPO), this indicator is critical: following costly clinical trials, the scaling of proprietary drugs sharply increases profitability. By analyzing the annual percentage growth of EPS TTM, an investor assesses the company's transition from the investment stage to the profit phase.

Competitor analysis for Lipella Pharmaceuticals

Earnings per share for the trailing year HLN (Haleon)|KVUE: Net earnings per share (EPS TTM)|Verona Pharma Corp - Earnings per share for the trailing year|MENS (Jyong Biotech Limited) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months ligand.com LGND|Earnings per share for the last twelve months Amneal (AMRX)|PRGO (Perrigo Company PLC) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALVO (Alvotech S.A.)|Liquidia Technologies - Earnings per share for the last twelve months|Galapagos Corp - Net earnings per share (EPS TTM)|ANIP (ANI Pharmaceuticals) - Earnings per share for the last 12 months|MannKind Corp. (MNKD) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Corp) - Net earnings per share (EPS TTM)|SPRY: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TBPH|Net earnings per share for the last four quarters Aquestive Therapeutics, Inc.|Earnings per share for the last twelve months scPharmaceuticals Inc. SCPH|TECX: Earnings per share for the last 12 months|TNXP - Earnings per share for the last twelve months|Net earnings per share for the last four quarters SXT Pharmaceuticals SXTC|EPRX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months bioharvest.com (BHST)|Net earnings per share for the last 12 months EXOZ|ORMP: Earnings per share for the trailing year|Earnings per share for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Therapeutics) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC (ABVC BioPharma, Inc)|Earnings per share for the trailing year CPIX|QNTM - Earnings per share for the last twelve months|FibroGen Corp (FGEN) - Net earnings per share for the last 12 months|Telomir Pharmaceuticals Corp (TELO) - Earnings per share for the last twelve months|Rani Therapeutics (RANI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Synergy CHC Corp.|Net earnings per one share for the last twelve months rallybio.com RLYB|Net earnings per share (EPS TTM) LEXX|PULM: Earnings per one share for the last 12 months|Pheton Holdings Ltd - Net earnings per share for the last 12 months|APM - Net earnings per share for the last 12 months|LYRA - Earnings per share for the last twelve months|Earnings per share for the trailing year IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Earnings per share for the last twelve months|cbdMD Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months PRFX|Altamira Therapeutics (CYTO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) OPTN|Net earnings per share (EPS TTM) pieris.com (PIRS)|Earnings per share for the last twelve months Procaps Group Corp PROC|Petros Pharmaceuticals Inc - Earnings per share for the last twelve months|Qilian International Corp - Net earnings per share (EPS TTM)|ACELYRIN, Inc. (SLRN) - Net earnings per share for the last 12 months|TFF Pharma (TFFP) - Earnings per share for the last twelve months